Statements in which the resource exists.
SubjectPredicateObjectContext
pubmed-article:20079359rdf:typepubmed:Citationlld:pubmed
pubmed-article:20079359lifeskim:mentionsumls-concept:C0087111lld:lifeskim
pubmed-article:20079359lifeskim:mentionsumls-concept:C0034693lld:lifeskim
pubmed-article:20079359lifeskim:mentionsumls-concept:C0018787lld:lifeskim
pubmed-article:20079359lifeskim:mentionsumls-concept:C0277785lld:lifeskim
pubmed-article:20079359lifeskim:mentionsumls-concept:C1706144lld:lifeskim
pubmed-article:20079359lifeskim:mentionsumls-concept:C1555029lld:lifeskim
pubmed-article:20079359lifeskim:mentionsumls-concept:C1999216lld:lifeskim
pubmed-article:20079359lifeskim:mentionsumls-concept:C0173022lld:lifeskim
pubmed-article:20079359pubmed:issue1lld:pubmed
pubmed-article:20079359pubmed:dateCreated2010-6-1lld:pubmed
pubmed-article:20079359pubmed:abstractTextThe PKC-beta inhibitor ruboxistaurin (RBX or LY333531) prevents diabetic renal and retinal microvascular complications. However, the effect of RBX on diabetic cardiac microvascular dysfunction is still unclear. In this study, we aimed to investigate the effects and mechanisms of RBX treatment upon cardiac endothelial barrier dysfunction in high glucose states. We demonstrated RBX treatment suppressed high glucose induced PKC-betaII activation and phosphorylation of beta-catenin in vivo and in vitro experiments. Meanwhile, RBX treatment protected cardiac microvascular barrier function in diabetic animals and monolayer barrier function of cultured cardiac microvascular endothelial cells (CMECs), reproducing the same effect as PKC-betaII siRNA. These results provide new insight into protective properties of PKC-beta inhibitor against cardiac endothelial barrier dysfunction. PKC-beta inhibitor RBX prevented chronic cardiac microvascular barrier dysfunction and improved endothelial cell-cell junctional function in high glucose states.lld:pubmed
pubmed-article:20079359pubmed:languageenglld:pubmed
pubmed-article:20079359pubmed:journalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:20079359pubmed:citationSubsetIMlld:pubmed
pubmed-article:20079359pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:20079359pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:20079359pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:20079359pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:20079359pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:20079359pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:20079359pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:20079359pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:20079359pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:20079359pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:20079359pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:20079359pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:20079359pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:20079359pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:20079359pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:20079359pubmed:statusMEDLINElld:pubmed
pubmed-article:20079359pubmed:monthJullld:pubmed
pubmed-article:20079359pubmed:issn1095-9319lld:pubmed
pubmed-article:20079359pubmed:authorpubmed-author:XXXlld:pubmed
pubmed-article:20079359pubmed:authorpubmed-author:DEH NHNlld:pubmed
pubmed-article:20079359pubmed:authorpubmed-author:RongqingZhang...lld:pubmed
pubmed-article:20079359pubmed:authorpubmed-author:LeeAndrewAlld:pubmed
pubmed-article:20079359pubmed:authorpubmed-author:WeiLipingLlld:pubmed
pubmed-article:20079359pubmed:authorpubmed-author:CaoFengFlld:pubmed
pubmed-article:20079359pubmed:authorpubmed-author:WangHaichangHlld:pubmed
pubmed-article:20079359pubmed:authorpubmed-author:HwangAndrewAlld:pubmed
pubmed-article:20079359pubmed:authorpubmed-author:YinZhiyongZlld:pubmed
pubmed-article:20079359pubmed:authorpubmed-author:SunDongdongDlld:pubmed
pubmed-article:20079359pubmed:authorpubmed-author:DiChunxiaClld:pubmed
pubmed-article:20079359pubmed:copyrightInfoCopyright 2009 Elsevier Inc. All rights reserved.lld:pubmed
pubmed-article:20079359pubmed:issnTypeElectroniclld:pubmed
pubmed-article:20079359pubmed:volume80lld:pubmed
pubmed-article:20079359pubmed:ownerNLMlld:pubmed
pubmed-article:20079359pubmed:authorsCompleteYlld:pubmed
pubmed-article:20079359pubmed:pagination158-65lld:pubmed
pubmed-article:20079359pubmed:meshHeadingpubmed-meshheading:20079359...lld:pubmed
pubmed-article:20079359pubmed:meshHeadingpubmed-meshheading:20079359...lld:pubmed
pubmed-article:20079359pubmed:meshHeadingpubmed-meshheading:20079359...lld:pubmed
pubmed-article:20079359pubmed:meshHeadingpubmed-meshheading:20079359...lld:pubmed
pubmed-article:20079359pubmed:meshHeadingpubmed-meshheading:20079359...lld:pubmed
pubmed-article:20079359pubmed:meshHeadingpubmed-meshheading:20079359...lld:pubmed
pubmed-article:20079359pubmed:meshHeadingpubmed-meshheading:20079359...lld:pubmed
pubmed-article:20079359pubmed:meshHeadingpubmed-meshheading:20079359...lld:pubmed
pubmed-article:20079359pubmed:meshHeadingpubmed-meshheading:20079359...lld:pubmed
pubmed-article:20079359pubmed:meshHeadingpubmed-meshheading:20079359...lld:pubmed
pubmed-article:20079359pubmed:meshHeadingpubmed-meshheading:20079359...lld:pubmed
pubmed-article:20079359pubmed:meshHeadingpubmed-meshheading:20079359...lld:pubmed
pubmed-article:20079359pubmed:meshHeadingpubmed-meshheading:20079359...lld:pubmed
pubmed-article:20079359pubmed:meshHeadingpubmed-meshheading:20079359...lld:pubmed
pubmed-article:20079359pubmed:meshHeadingpubmed-meshheading:20079359...lld:pubmed
pubmed-article:20079359pubmed:meshHeadingpubmed-meshheading:20079359...lld:pubmed
pubmed-article:20079359pubmed:meshHeadingpubmed-meshheading:20079359...lld:pubmed
pubmed-article:20079359pubmed:meshHeadingpubmed-meshheading:20079359...lld:pubmed
pubmed-article:20079359pubmed:meshHeadingpubmed-meshheading:20079359...lld:pubmed
pubmed-article:20079359pubmed:meshHeadingpubmed-meshheading:20079359...lld:pubmed
pubmed-article:20079359pubmed:meshHeadingpubmed-meshheading:20079359...lld:pubmed
pubmed-article:20079359pubmed:meshHeadingpubmed-meshheading:20079359...lld:pubmed
pubmed-article:20079359pubmed:meshHeadingpubmed-meshheading:20079359...lld:pubmed
pubmed-article:20079359pubmed:meshHeadingpubmed-meshheading:20079359...lld:pubmed
pubmed-article:20079359pubmed:meshHeadingpubmed-meshheading:20079359...lld:pubmed
pubmed-article:20079359pubmed:year2010lld:pubmed
pubmed-article:20079359pubmed:articleTitleA PKC-beta inhibitor treatment reverses cardiac microvascular barrier dysfunction in diabetic rats.lld:pubmed
pubmed-article:20079359pubmed:affiliationDepartment of Cardiology, Xijing Hospital, Fourth Military Medical University, Xi'an, Shaanxi, China.lld:pubmed
pubmed-article:20079359pubmed:publicationTypeJournal Articlelld:pubmed
pubmed-article:20079359pubmed:publicationTypeResearch Support, Non-U.S. Gov'tlld:pubmed
http://linkedlifedata.com/r...pubmed:referesTopubmed-article:20079359lld:pubmed